Novo seeks US$830 million from Singapore firm, accusing it of fraud over drug
Novo Nordisk is seeking as much as US$830 million in damages in a Singapore court, saying it was misled by ...
Tag: US830
Singaporean Huang Zhenhua’s assets frozen over US$830 million suit by drug giant Novo
Novo Nordisk is seeking as much as US$830 million in damages in a Singapore court, saying that it was misled ...
Singapore court freezes worldwide assets in US$830 million Novo Nordisk suit
The Danish drugmaker alleges misrepresentations by biotech firm founder Huang Zhenhua about the success of its kidney drug PHARMA giant ...
China to invest more than US$830 million in solid-state battery research
China plans to invest more than US$830 million in a government-led project to develop solid-state batteries with six firms eligible ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.